- Home
- FNWD vs ALGS Comparison
FNWD vs ALGS Comparison
Compare FNWD & ALGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FNWD
- ALGS
- Stock Information
- Founded
- FNWD 1994
- ALGS 2018
- Country
- FNWD United States
- ALGS United States
- Employees
- FNWD N/A
- ALGS N/A
- Industry
- FNWD Savings Institutions
- ALGS Biotechnology: Pharmaceutical Preparations
- Sector
- FNWD Finance
- ALGS Health Care
- Exchange
- FNWD Nasdaq
- ALGS Nasdaq
- Market Cap
- FNWD 137.4M
- ALGS 118.8M
- IPO Year
- FNWD N/A
- ALGS 2020
- Fundamental
- Price
- FNWD $30.21
- ALGS $39.84
- Analyst Decision
- FNWD
- ALGS Strong Buy
- Analyst Count
- FNWD 0
- ALGS 1
- Target Price
- FNWD N/A
- ALGS $75.00
- AVG Volume (30 Days)
- FNWD 4.1K
- ALGS 428.8K
- Earning Date
- FNWD 01-28-2025
- ALGS 11-06-2024
- Dividend Yield
- FNWD 1.59%
- ALGS N/A
- EPS Growth
- FNWD 7.22
- ALGS N/A
- EPS
- FNWD 2.71
- ALGS N/A
- Revenue
- FNWD $69,627,000.00
- ALGS $5,997,000.00
- Revenue This Year
- FNWD N/A
- ALGS N/A
- Revenue Next Year
- FNWD $1.04
- ALGS N/A
- P/E Ratio
- FNWD $11.15
- ALGS N/A
- Revenue Growth
- FNWD 3.96
- ALGS N/A
- 52 Week Low
- FNWD $22.82
- ALGS $6.76
- 52 Week High
- FNWD $33.50
- ALGS $41.64
- Technical
- Relative Strength Index (RSI)
- FNWD 43.77
- ALGS 80.76
- Support Level
- FNWD $29.31
- ALGS $28.00
- Resistance Level
- FNWD $31.16
- ALGS $35.89
- Average True Range (ATR)
- FNWD 0.38
- ALGS 4.05
- MACD
- FNWD -0.11
- ALGS 0.51
- Stochastic Oscillator
- FNWD 41.10
- ALGS 89.77
About FNWD Finward Bancorp
Finward Bancorp is a bank holding company, which engages in the provision of financial services. It offers products and services related to Personal Banking, Cash Management, Saving Account, ebanking, Wealth Management, and Insurance Services. It is engaged in the business of attracting deposits from the general public and the origination of loans, mostly upon the security of single-family residences and commercial real estate, construction loans, commercial business loans, and municipal loans. Geographically, the activities are carried out through the United States.
About ALGS Aligos Therapeutics Inc.
Aligos Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.